Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.355 USD | +1.91% |
|
+21.30% | +36.75% |
Jul. 01 | Raymond James Initiates AxoGen at Outperform With $13 Price Target | MT |
Jun. 24 | Axogen, Inc. Announces Full Launch of Avive+ Soft Tissue Matrix | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.75% | 401M | |
+4.81% | 212B | |
+8.71% | 187B | |
+27.42% | 155B | |
+34.25% | 115B | |
+2.17% | 65.5B | |
+13.83% | 52.87B | |
-3.30% | 45.25B | |
-3.59% | 39.7B | |
+6.61% | 37.72B |
- Stock Market
- Equities
- AXGN Stock
- News AxoGen, Inc.
- AxoGen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2020